stroke/albumin

Länken sparas på Urklipp

Välj sorteringstyp

Sida 1 från 1422 resultat

Serum albumin and self-reported prevalence of stroke: a population-based, cross-sectional study.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND Since information about the association between serum albumin and risk of stroke is limited the purpose of the present paper was to re-investigate this relationship. METHODS The study followed a cross-sectional design. METHODS In the cross-sectional Norwegian Oslo Health Study the

Albumin therapy in acute stroke patients.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Preclinical studies have recently shown that albumin has neuroprotective effects for stroke in animal models. Thus, we sought to evaluate the effects of albumin therapy in patients with acute cerebral infarcts. We prospectively studied 49 patients with moderate-to-severe cerebral infarcts within the

Albumin reduces blood-brain barrier permeability but does not alter infarct size in a rat model of neonatal stroke.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Human serum albumin therapy confers neurobehavioral and histopathologic neuroprotection in adult stroke models. We investigated whether albumin might also be neuroprotective in ischemic brain injury using a transient filament middle cerebral artery occlusion (tfMCAO) model in 10-d-old rat pups

Assessment of serum albumin concentration as a risk factor for stroke and coronary disease in African Americans and whites.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Relatively high serum albumin levels compared to low levels have been associated with reduced cardiovascular mortality and coronary heart disease and stroke incidence. The nature of these associations remains undefined. Therefore, widely accepted criteria of Bradford Hill were used to assess the

Could pro-BNP, uric acid, bilirubin, albumin and transferrin be used in making the distinction between stroke subtypes?

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

To establish the pathogenesis of ischemic strokes is very important in determining an adequate therapy. The objective was to observe if certain plasma parameters could be used as biomarkers in distinguishing between stroke subtypes. Plasma pro-BNP (chemiluminescence), serum uric acid, bilirubin

Prognostic significance of ischemia-modified albumin in acute ischemic stroke patients: A preliminary study.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND Ischemia-modified albumin (IMA) is a sensitive marker of ischemic event. However, limited studies are available regarding role of IMA in acute ischemic stroke (AIS). OBJECTIVE The aim of this study was to evaluate time course of IMA in AIS patient to validate its prognostic

Myelin basic protein and ischemia modified albumin levels in acute ischemic stroke cases.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

OBJECTIVE To investigate early diagnostic effects of serum myelin basic protein (MBP) and ischemic modified albumin (IMA) levels in patients with ischemic stroke. METHODS Fifty patients who presented to an emergency service with acute ischemic stroke between June 2013 to March 2014 were evaluated

Delayed treatment with polynitroxyl albumin reduces infarct size after stroke in rats.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Nitroxides are antioxidants that are known to protect cells from oxidative damage. Polynitroxyl albumin (PNA) is a compound of human serum albumin covalently labeled with nitroxides that exhibits a prolonged half-life and an enhanced antioxidant activity. Adult male Sprague-Dawley rats were

fMRI of delayed albumin treatment during stroke recovery in rats: implication for fast neuronal habituation in recovering brains.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Accumulating experimental and clinical data suggest that albumin may be neuroprotective for stroke. Here, we use functional magnetic resonance imaging (fMRI) to evaluate the therapeutic efficacy of albumin and its effects on the recovery of stimuli-induced cerebral hemodynamics. For this purpose,

Dendrimer grafted albumin nanoparticles for the treatment of post cerebral stroke damages: A proof of concept study.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Stroke is the second largest disease of mortality. The biggest hurdle in designing effective brain drug delivery systems is offered by the blood-brain barrier (BBB), which is highly impermeable to many drugs. Albumin nanoparticles (NP) have gained attention due to their multiple ligand binding sites

Transient forebrain ischemia increases the blood-brain barrier permeability for albumin in stroke-prone spontaneously hypertensive rats.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

1. The aim of the present study was to reveal the effect of transient forebrain ischemia on the regional and temporal changes in the permeability of the blood-brain barrier (BBB) permeability for sodium fluorescein (MW: 376 Da) and Evan's blue-labeled albumin (MW: 67 kDa) in stroke-prone

Ischemia-modified albumin and heart fatty acid-binding protein: could early ischemic cardiac biomarkers be used in acute stroke management?

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND The detection of biomarkers such as ischemia-modified albumin (IMA) and heart fatty acid-binding protein (HFABP) is used in the early diagnosis of acute myocardial infarction. As these biomarkers are not organ specific, we tested them in the neurovascular field. METHODS A total of 41

Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND Albumin treatment of ischemic stroke was associated with cardiopulmonary adverse events in previous studies and a low incidence of intracranial hemorrhage. We sought to describe the neurological and cardiopulmonary adverse events in the ALIAS Part 2 Multicenter Trial. METHODS Ischemic

Ability of B-Type Natriuretic Peptide Testing to Predict Cardioembolic Stroke in the General Population　- Comparisons With C-Reactive Protein and Urinary Albumin.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND The ability of cardiovascular biomarkers to predict the incidence of stroke subtypes remains ill-defined in the general population.Methods and Results:The blood levels of B-type natriuretic peptide (BNP) and high-sensitivity C-reactive protein (hs-CRP) and urinary albumin corrected by

Prognostic significance of serum albumin level changes in acute ischemic stroke: the role of biological and analytical variation.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND Animal studies have shown a neuroprotective effect of human serum albumin (sAlb) in ischemic stroke (IS). Previous studies have shown an association of high sAlb with better outcome. Our aim is to investigate the kinetics of sAlb in acute IS and its possible correlation with outcome

Tidigare
1
2
3
4
5
6
...
94
95
Nästa

Gå med på vår
facebook-sida

Herbal & Natural Medicine

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

Fungerar på 55 språk
Växtbaserade botemedel som stöds av vetenskap
Örter igenkänning av bild
Interaktiv GPS-karta - märka örter på plats (kommer snart)
Läs vetenskapliga publikationer relaterade till din sökning
Sök efter medicinska örter efter deras effekter
Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning

stroke/albumin

Serum albumin and self-reported prevalence of stroke: a population-based, cross-sectional study.

Albumin therapy in acute stroke patients.

Albumin reduces blood-brain barrier permeability but does not alter infarct size in a rat model of neonatal stroke.

Assessment of serum albumin concentration as a risk factor for stroke and coronary disease in African Americans and whites.

Could pro-BNP, uric acid, bilirubin, albumin and transferrin be used in making the distinction between stroke subtypes?

Prognostic significance of ischemia-modified albumin in acute ischemic stroke patients: A preliminary study.

Myelin basic protein and ischemia modified albumin levels in acute ischemic stroke cases.

Delayed treatment with polynitroxyl albumin reduces infarct size after stroke in rats.

fMRI of delayed albumin treatment during stroke recovery in rats: implication for fast neuronal habituation in recovering brains.

Dendrimer grafted albumin nanoparticles for the treatment of post cerebral stroke damages: A proof of concept study.

Transient forebrain ischemia increases the blood-brain barrier permeability for albumin in stroke-prone spontaneously hypertensive rats.

Ischemia-modified albumin and heart fatty acid-binding protein: could early ischemic cardiac biomarkers be used in acute stroke management?

Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial.

Ability of B-Type Natriuretic Peptide Testing to Predict Cardioembolic Stroke in the General Population - Comparisons With C-Reactive Protein and Urinary Albumin.

Prognostic significance of serum albumin level changes in acute ischemic stroke: the role of biological and analytical variation.

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

Ability of B-Type Natriuretic Peptide Testing to Predict Cardioembolic Stroke in the General Population　- Comparisons With C-Reactive Protein and Urinary Albumin.